Shire Acquires Lotus Tissue Repair, Inc.

HGT Pipeline Enhanced with Protein Replacement Therapy Being Investigated for the Treatment of Dystrophic Epidermolysis Bullosa LEXINGTON, Massachusetts, January 8, 2013 /PRNewswire/ --Shire plc (LSE: SHP, NASDAQ: SHPG), announces that it has...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news